Get the Stockscreener App
0.2906
7.23%
-0.0247
Renovaro Inc stock is traded at $0.2906, with a volume of 841.00K.
It is down -7.23% in the last 24 hours and down -0.07% over the past month.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
See More
Previous Close:
$0.3153
Open:
$0.3199
24h Volume:
841.00K
Relative Volume:
0.25
Market Cap:
$50.02M
Revenue:
-
Net Income/Loss:
$-41.23M
P/E Ratio:
-0.4151
EPS:
-0.7
Net Cash Flow:
$-11.54M
1W Performance:
-5.09%
1M Performance:
-0.07%
6M Performance:
-61.67%
1Y Performance:
-75.11%
1-Day Range:
$0.2836
$0.3199
1-Week Range:
$0.2836
$0.35
52-Week Range:
$0.264
$2.10
Renovaro Inc Stock (RENB) Company Profile
Name
Renovaro Inc
Sector
Industry
Phone
45 39179840
Address
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Compare RENB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RENB
Renovaro Inc
|
0.2906 | 69.72M | 0 | -41.23M | -11.54M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.24 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.07 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
326.18 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
596.17 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.68 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovaro Inc Stock (RENB) Latest News
How did Renovaro's expenses impact profits in Q2 2025? - AInvest
Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector - USA Today
Renovaro BioSciences secures multiple U.S. patents in biomedical AI - TipRanks
Renovaro (RENB) Fortifies Position with New U.S. Patent Approvals - GuruFocus
Renovaro Lands Game-Changing AI Patents for $20B Healthcare Market: Key Tech Details Revealed - Stock Titan
What are the latest earnings results for Renovaro Inc.Free Market Dynamics Reports - jammulinksnews.com
Elliott Wave Theory Predicts Pullback in Renovaro Inc.Scalable Portfolio Growth Suggestions Released - metal.it
Should I hold or sell Renovaro Inc. stock in 2025Daily Trading Review That Work - jammulinksnews.com
What institutional investors are buying Renovaro Inc. stockBuild wealth steadily with proven stock picks - jammulinksnews.com
Is it the right time to buy Renovaro Inc. stockCapitalize on market opportunities with confidence - jammulinksnews.com
What makes Renovaro Inc. stock price move sharplyDiscover high-impact stocks for your portfolio - jammulinksnews.com
Is Renovaro Inc. stock overvalued or undervaluedUnlock powerful trading techniques - jammulinksnews.com
How many analysts rate Renovaro Inc. as a “Buy”Maximize portfolio growth with professional advice - jammulinksnews.com
What are the technical indicators suggesting about Renovaro Inc.Capitalize on market trends before they peak - jammulinksnews.com
Renovaro chairman Maurice van Tilburg to step down in August - Investing.com Australia
Is Renovaro Inc. a good long term investmentHigh-impact investment strategies - PrintWeekIndia
Renovaro Biosciences Chairman Announces Resignation - TipRanks
Renovaro Inc. Stock Analysis and ForecastHigh-profit capital plays - PrintWeekIndia
What drives Renovaro Inc. stock priceJaw-dropping returns - Autocar Professional
What analysts say about Renovaro Inc. stockTremendous portfolio expansion - Autocar Professional
How high can Renovaro Inc. stock price go in 2025Tremendous return rates - jammulinksnews.com
Can Renovaro Inc. stock recover from recent declineDaily Breakout Picks - Newser
Renovaro Inc Stock (RENB) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.68%
2.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):